Biotech Takeover Targets Wall Street Eyes After Apogee Deal
AbbVie’s Apogee deal has revived takeover chatter. Three Nasdaq-listed biotech players are emerging as plausible biot...
Knowing when to save money and when to invest is vital for financial success. This article provides insights on timing your decisions.
28,655 articlesAbbVie’s Apogee deal has revived takeover chatter. Three Nasdaq-listed biotech players are emerging as plausible biot...
A 65-year-old with $1.4 million outlines a three-stock income plan focused on essential networks—defense, pipelines, ...
Lilly is backing Absci with a $40 million investment as Absci advances ABS-201, a next-gen injectable targeting hair ...
A blockbuster year for Delek US Holdings brought attention to a notable insider move. The event described as delek in...
Alibaba leads a broad rally in China’s tech and e-commerce sector as investors brace for quarterly results. Baidu and...
Oil prices slide and spike in turn as Strait of Hormuz tensions flare. Trump’s time running avoid weighs on markets a...
Analysts publish an eyebrow-raising spacex’s $800 price target, implying a potential trillion-dollar leap in value an...
When a CFO sells a notable chunk of stock, investors want clarity. This article breaks down what CoreWeave's sold com...
A major biotech stake shift signals evolving risk appetite. We break down the $125 million trim by ORBIMED Advisors, ...
A bipartisan bill aims block large investment firms from purchasing single-family homes, a move supporters say would ...
Ethereum struggles to form a durable base as macro uncertainty persists. This ethereum price prediction piece surveys...
Marvell Technology defied earlier sell-offs tied to fears of losing Amazon and Microsoft to rivals, reporting strong ...